We are live on
!
Find out more
JSP
Jackson Square Partners Portfolio holdings
AUM
$247M
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter
Est. Return
+9.97%
1 Year Est. Return
+20.29%
3 Year Est. Return
+101.87%
5 Year Est. Return
+75.18%
10 Year Est. Return
+392.81%
AUM
$21.4B
AUM Growth
+$1.44B
(+7.2%)
Cap. Flow
-$491M
Cap. Flow
% of AUM
-2.3%
Top 10 Holdings %
Top 10 Hldgs %
35.67%
Holding
94
New
5
Increased
29
Reduced
48
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$469M |
| 2 |
Match Group
MTCH
|
+$337M |
| 3 |
WIX.com
WIX
|
+$158M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$139M |
| 5 |
Paycom
PAYC
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$410M |
| 2 |
IQVIA
IQV
|
+$232M |
| 3 |
Microsoft
MSFT
|
+$214M |
| 4 |
Haemonetics
HAE
|
+$206M |
| 5 |
CME Group
CME
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.26% |
| 2 | Consumer Discretionary | 14.01% |
| 3 | Financials | 13.56% |
| 4 | Communication Services | 13.23% |
| 5 | Healthcare | 12.07% |
Similar funds
OIA
SRC
TCB
MTWM
SSW
WS
FC
KSWA
Jackson Square Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Jackson Square Partners held 94 positions worth $21.4B, up 7.2% from $19.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jackson Square Partners's Q3 2020 filing shows 5 new, 29 increased, 48 reduced and 8 closed positions. Its largest new stake was Edwards Lifesciences: 6,016,819 shares worth $480M. The largest sale was UnitedHealth, an estimated $410M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jackson Square Partners's largest Q3 2020 buy was Edwards Lifesciences: 6,016,819 shares worth $480M.
- Jackson Square Partners added most to Match Group in Q3 2020, an estimated $337M increase.
- Jackson Square Partners's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $410M.
- Jackson Square Partners fully exited Haemonetics in Q3 2020, selling an estimated $206M.
- Jackson Square Partners's ten largest holdings make up 36% of its $21.4B portfolio in Q3 2020.
- Jackson Square Partners opened 5 new positions and closed 8 in Q3 2020.
- Jackson Square Partners's portfolio value rose 7.2% quarter-over-quarter to $21.4B.
Based on Jackson Square Partners's 13F filing for Q3 2020, filed 13 Nov 2020.